pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-7113 |
Genomic Coordinates | chr11: 68032864 - 68032922 |
Description | Homo sapiens miR-7113 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-7113-5p | ||||||||||||||||||||||||
Sequence | 2| UCCAGGGAGACAGUGUGUGAG |22 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Meta-analysis | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SIN3B | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | SIN3 transcription regulator family member B | ||||||||||||||||||||
Transcript | NM_015260 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SIN3B | |||||||||||||||||||||
3'UTR of SIN3B (miRNA target sites are highlighted) |
>SIN3B|NM_015260|3'UTR 1 CCCGCCCTCATGGGCACCGGGCAGGCGCCTCACAGAGCACAGACGTGCCCTCGGCCTTGGTCGTGTCGGGGCCGTTTTCT 81 TGAACGACGTGAGAGGCATCTCCCAGCCCCTCTGCTGCCGGACAGCGCACTCCAGGGCAGGACGCCGCCCCCGTGGCTCC 161 CGGTCTCCTGTGGGCCTGCTGTGTGCCAAACCTGAGCTACCTGCACCCGAGCCCTGGGGCTCAGCCCCACCACAGGGGCG 241 GGTGGACGTGCTGGCCGAGGAACAAGCAATCATGTTTGCGTCCCCGTCCGTCACATGTGCCAAATCCCTGGCAGGCAGAT 321 GGCTCCTGCCCCATATTCTTGCCGTGTCTTGGAAAAGTCACAGGTGACAGCCCTCCTGAGGCCCACACTTTGGAGGGGGT 401 CCATGTCCAAGAGACCCTGACAAGGAAGGAGTTGAGCCCTGGGTAGGCTTGCTTGAAAAGTGAGTCCTTCCAGAATATTC 481 TCAGAGCTGCCAGAAACATCATCTGAGGGTTTGGGCATCAGCTCTGCCTGGCTGGTGTTCAGGCCCTCAGTCACTTTGGA 561 AGTGAGAAGAACCCTTCAGCCAAACCTTTGGGATCCCATTTTGAAGTCCAGAGCTGGAGCAGGCGGGCAGTGCCCTGGGA 641 GACCCCGCTCTGGATAAGACACCCAACCCCAACTCCAGCAGCTGGACTCTGGGCCCACAAGGGGAGGGACCCCAGCCAGT 721 ATTCCCTCAGAGCCGGCACGACCCTGCTGTGGGGCGGCGGGCCCAGTCGTGTTCCTGCAGTGGGCACCCTAGGCGTATGT 801 GTATACACGCACAGATATTTATTCCTTTCGCTTTTAGTGGTTGTTATTTCTGTAGCAGCCAAGTCCTGCGGCTCCCTGGG 881 GCTGAGATCTCCCTTTGTGGAACTCCGAGAGCCGCCCTGACAGTCCCAGCCGCCACCCAAGGAGCCCCATCCGCCCACCC 961 ACCCTGGGACCCACGCGGCCACTCCAGGGATCATTGTTGTCCTTTTGTGAGGGGCTGAGGCGACTGTCCCATGGAGGCAT 1041 CCAAGGCTTTCTGTGCCAAGAATCCCAAGTGACTGGGGCTGGGGACCACTTCTCCAGGCCTCTCTCCCCGACCATGAGAG 1121 CCCCTGGCCCTGGCCCCTGCACACCAGTAGGCCCAGAATAACCGCCACCCTTGCCATCCTGCAACAGCTGGACTCAAGTT 1201 TCCAGGAAGTGGAGATGTGTTTCTAGAAGTTTCCTGTGGAACCTGGAGGCTCCTGATGCCTTTGACTCCAGGCTGGGCGA 1281 TTCCGATGCTGACCCGTCCTCCTGGGCTCCCCACCCCCGCTCCCCAAGTGTCACACAGGCACTTTGTACACATCCTGGTT 1361 TTCTAAGAAGGGAACTTGCCATCAAGATTCCTGTACCAGGCCCACGGCCGTCTCGGGCAGAGCCACCTGGGCCCCGGGTG 1441 CAGCCGGAGACCCCGCCGAGCCCCTCCTCCCAGTATTCCCATCCCCGCATGCTTCTAGGGAGCGCCTCTTTTCCGTTCTT 1521 GAGGAATTTCTGTTCTGGGGCTTGTCCTTCCTTTGCAGCTGTTTTGAATGTAGTTTTCCTTTTCTATTTATTTGCACATT 1601 AAAGTTAATAATTGAATATTGACATC Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HCT116 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in ERX177615. RNA binding protein: AGO2. Condition:p53_D_AGO_CLIP_3_5
... - Krell J; Stebbing J; Carissimi C; Dabrowska et al., 2016, Genome research. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Krell J; Stebbing J; Carissimi C; Dabrowska et al. - Genome research, 2016
DNA damage activates TP53-regulated surveillance mechanisms that are crucial in suppressing tumorigenesis. TP53 orchestrates these responses directly by transcriptionally modulating genes, including microRNAs (miRNAs), and by regulating miRNA biogenesis through interacting with the DROSHA complex. However, whether the association between miRNAs and AGO2 is regulated following DNA damage is not yet known. Here, we show that, following DNA damage, TP53 interacts with AGO2 to induce or reduce AGO2's association of a subset of miRNAs, including multiple let-7 family members. Furthermore, we show that specific mutations in TP53 decrease rather than increase the association of let-7 family miRNAs, reducing their activity without preventing TP53 from interacting with AGO2. This is consistent with the oncogenic properties of these mutants. Using AGO2 RIP-seq and PAR-CLIP-seq, we show that the DNA damage-induced increase in binding of let-7 family members to the RISC complex is functional. We unambiguously determine the global miRNA-mRNA interaction networks involved in the DNA damage response, validating them through the identification of miRNA-target chimeras formed by endogenous ligation reactions. We find that the target complementary region of the let-7 seed tends to have highly fixed positions and more variable ones. Additionally, we observe that miRNAs, whose cellular abundance or differential association with AGO2 is regulated by TP53, are involved in an intricate network of regulatory feedback and feedforward circuits. TP53-mediated regulation of AGO2-miRNA interaction represents a new mechanism of miRNA regulation in carcinogenesis.
LinkOut: [PMID: 26701625]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000379803.1 | 3UTR | UCCCCGUCCGUCACAUGUGCCAAAUCCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
104 hsa-miR-7113-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT059935 | ZDHHC5 | zinc finger DHHC-type containing 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT083388 | E2F1 | E2F transcription factor 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT183511 | BTG2 | BTG anti-proliferation factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT192333 | KLF13 | Kruppel like factor 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT347200 | SIN3B | SIN3 transcription regulator family member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT451431 | TJP3 | tight junction protein 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT452499 | HMGXB3 | HMG-box containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453830 | SAA1 | serum amyloid A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454309 | ZNF134 | zinc finger protein 134 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454833 | POLR2J3 | RNA polymerase II subunit J3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT454890 | RAD50 | RAD50 double strand break repair protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT455881 | KIF2C | kinesin family member 2C | ![]() |
![]() |
2 | 2 | ||||||
MIRT456161 | TTF2 | transcription termination factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT456945 | LRP10 | LDL receptor related protein 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT457627 | UPK3BL | uroplakin 3B like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459486 | CCL11 | C-C motif chemokine ligand 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT459585 | NLGN2 | neuroligin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT460719 | FN3KRP | fructosamine 3 kinase related protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT461576 | SCO1 | SCO1, cytochrome c oxidase assembly protein | ![]() |
![]() |
2 | 4 | ||||||
MIRT461817 | SNAP23 | synaptosome associated protein 23 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462409 | RBM28 | RNA binding motif protein 28 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462434 | GTPBP10 | GTP binding protein 10 | ![]() |
![]() |
2 | 4 | ||||||
MIRT462523 | ZNF500 | zinc finger protein 500 | ![]() |
![]() |
2 | 2 | ||||||
MIRT462787 | ZNF8 | zinc finger protein 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT463898 | WNT7B | Wnt family member 7B | ![]() |
![]() |
2 | 4 | ||||||
MIRT466954 | STAT3 | signal transducer and activator of transcription 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT467035 | SRSF1 | serine and arginine rich splicing factor 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT467436 | SND1 | staphylococcal nuclease and tudor domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT468780 | SCD | stearoyl-CoA desaturase | ![]() |
![]() |
2 | 2 | ||||||
MIRT469765 | RAB2B | RAB2B, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT470784 | PNPLA6 | patatin like phospholipase domain containing 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT471842 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472222 | NGFR | nerve growth factor receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT472538 | NACC1 | nucleus accumbens associated 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472937 | MSN | moesin | ![]() |
![]() |
2 | 2 | ||||||
MIRT477462 | ELMSAN1 | ELM2 and Myb/SANT domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT479077 | CNNM4 | cyclin and CBS domain divalent metal cation transport mediator 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT479260 | CHSY1 | chondroitin sulfate synthase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT480254 | C8orf58 | chromosome 8 open reading frame 58 | ![]() |
![]() |
2 | 2 | ||||||
MIRT480552 | BZW1 | basic leucine zipper and W2 domains 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT480929 | BCAT1 | branched chain amino acid transaminase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT482048 | AMD1 | adenosylmethionine decarboxylase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT483182 | HIST1H2AH | histone cluster 1 H2A family member h | ![]() |
![]() |
2 | 8 | ||||||
MIRT486998 | ZFAND2B | zinc finger AN1-type containing 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT488253 | DNLZ | DNL-type zinc finger | ![]() |
![]() |
2 | 4 | ||||||
MIRT488588 | ST7L | suppression of tumorigenicity 7 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT491068 | ACVR1B | activin A receptor type 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT492618 | PNRC1 | proline rich nuclear receptor coactivator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493817 | FSCN1 | fascin actin-bundling protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495988 | LTBP2 | latent transforming growth factor beta binding protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499248 | VAV3 | vav guanine nucleotide exchange factor 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT500451 | ZFP36L1 | ZFP36 ring finger protein like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT508311 | RPL18 | ribosomal protein L18 | ![]() |
![]() |
2 | 4 | ||||||
MIRT509711 | ANKRD23 | ankyrin repeat domain 23 | ![]() |
![]() |
2 | 2 | ||||||
MIRT531511 | NONO | non-POU domain containing octamer binding | ![]() |
![]() |
2 | 2 | ||||||
MIRT531711 | ABCB6 | ATP binding cassette subfamily B member 6 (Langereis blood group) | ![]() |
![]() |
2 | 2 | ||||||
MIRT533753 | TMEM184B | transmembrane protein 184B | ![]() |
![]() |
2 | 2 | ||||||
MIRT535987 | MED28 | mediator complex subunit 28 | ![]() |
![]() |
2 | 4 | ||||||
MIRT537865 | EDA2R | ectodysplasin A2 receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT539922 | DUSP28 | dual specificity phosphatase 28 | ![]() |
![]() |
2 | 2 | ||||||
MIRT541124 | RAB34 | RAB34, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT543053 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | ![]() |
![]() |
2 | 2 | ||||||
MIRT562618 | BCL7A | BCL tumor suppressor 7A | ![]() |
![]() |
2 | 2 | ||||||
MIRT563606 | ZNF277 | zinc finger protein 277 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573680 | HES6 | hes family bHLH transcription factor 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT609224 | TMEM178B | transmembrane protein 178B | ![]() |
![]() |
2 | 2 | ||||||
MIRT611658 | LIPC | lipase C, hepatic type | ![]() |
![]() |
2 | 2 | ||||||
MIRT612822 | KLHL3 | kelch like family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT613217 | CCDC85C | coiled-coil domain containing 85C | ![]() |
![]() |
2 | 4 | ||||||
MIRT617687 | MAPKBP1 | mitogen-activated protein kinase binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT618536 | TMEM241 | transmembrane protein 241 | ![]() |
![]() |
2 | 2 | ||||||
MIRT622094 | SRCIN1 | SRC kinase signaling inhibitor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT627600 | SGK494 | uncharacterized serine/threonine-protein kinase SgK494 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637157 | PCDHA6 | protocadherin alpha 6 | ![]() |
![]() |
2 | 4 | ||||||
MIRT642156 | AQR | aquarius intron-binding spliceosomal factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT643941 | WIPF3 | WAS/WASL interacting protein family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT646855 | SLC35E4 | solute carrier family 35 member E4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT647401 | SPNS2 | sphingolipid transporter 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648708 | TNFRSF13C | TNF receptor superfamily member 13C | ![]() |
![]() |
2 | 2 | ||||||
MIRT655571 | OXSR1 | oxidative stress responsive 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT655878 | NFASC | neurofascin | ![]() |
![]() |
2 | 2 | ||||||
MIRT660309 | BHLHE40 | basic helix-loop-helix family member e40 | ![]() |
![]() |
2 | 2 | ||||||
MIRT664073 | ZNF417 | zinc finger protein 417 | ![]() |
![]() |
2 | 2 | ||||||
MIRT667522 | LUC7L2 | LUC7 like 2, pre-mRNA splicing factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT667852 | IPCEF1 | interaction protein for cytohesin exchange factors 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT669240 | C7orf55-LUC7L2 | C7orf55-LUC7L2 readthrough | ![]() |
![]() |
2 | 2 | ||||||
MIRT674763 | QRSL1 | glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT679704 | GRK4 | G protein-coupled receptor kinase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT681445 | CIITA | class II major histocompatibility complex transactivator | ![]() |
![]() |
2 | 2 | ||||||
MIRT684814 | BRIX1 | BRX1, biogenesis of ribosomes | ![]() |
![]() |
2 | 2 | ||||||
MIRT694604 | AAR2 | AAR2 splicing factor homolog | ![]() |
![]() |
2 | 2 | ||||||
MIRT696944 | CERK | ceramide kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT704430 | CTNNBIP1 | catenin beta interacting protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708304 | MPPE1 | metallophosphoesterase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708874 | TMEM151B | transmembrane protein 151B | ![]() |
![]() |
2 | 2 | ||||||
MIRT713557 | TBC1D22B | TBC1 domain family member 22B | ![]() |
![]() |
2 | 2 | ||||||
MIRT714998 | TSPAN11 | tetraspanin 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT715993 | ACOT2 | acyl-CoA thioesterase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718872 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | ![]() |
![]() |
2 | 2 | ||||||
MIRT719664 | DMRT2 | doublesex and mab-3 related transcription factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT720825 | C6orf89 | chromosome 6 open reading frame 89 | ![]() |
![]() |
2 | 2 | ||||||
MIRT723357 | ASCL2 | achaete-scute family bHLH transcription factor 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724561 | SIT1 | signaling threshold regulating transmembrane adaptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT732592 | WNT10B | Wnt family member 10B | ![]() |
![]() |
2 | 0 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|